Daniel R. Premkumar

2.5k total citations
44 papers, 1.9k citations indexed

About

Daniel R. Premkumar is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Daniel R. Premkumar has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 14 papers in Physiology and 8 papers in Cancer Research. Recurrent topics in Daniel R. Premkumar's work include Alzheimer's disease research and treatments (9 papers), Cell death mechanisms and regulation (7 papers) and Histone Deacetylase Inhibitors Research (7 papers). Daniel R. Premkumar is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Cell death mechanisms and regulation (7 papers) and Histone Deacetylase Inhibitors Research (7 papers). Daniel R. Premkumar collaborates with scholars based in United States, India and Kenya. Daniel R. Premkumar's co-authors include Ian F. Pollack, Esther P. Jane, Raj N. Kalaria, David Cohen, Robert P. Friedland, Peter Hedera, Rajesh N. Kalaria, Nanduri R. Prabhakar, Joseph C. LaManna and Beth Arnold and has published in prestigious journals such as Cancer Research, Journal of Applied Physiology and Annals of the New York Academy of Sciences.

In The Last Decade

Daniel R. Premkumar

44 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Daniel R. Premkumar 956 648 304 289 195 44 1.9k
Christer Möller 1.0k 1.1× 992 1.5× 288 0.9× 265 0.9× 257 1.3× 61 2.9k
Tomoko Kurata 1.2k 1.2× 396 0.6× 752 2.5× 372 1.3× 98 0.5× 87 2.5k
Huang Guo 601 0.6× 910 1.4× 245 0.8× 672 2.3× 252 1.3× 19 2.2k
Virginia Hovanesian 370 0.4× 791 1.2× 139 0.5× 476 1.6× 130 0.7× 18 1.4k
Aimee W. Kao 1.1k 1.1× 664 1.0× 440 1.4× 218 0.8× 141 0.7× 38 2.1k
Sybille Krauß 1.3k 1.4× 573 0.9× 253 0.8× 270 0.9× 71 0.4× 43 2.1k
Nobuyuki Kimura 779 0.8× 736 1.1× 195 0.6× 276 1.0× 96 0.5× 56 1.6k
Ju Gao 1.1k 1.2× 471 0.7× 383 1.3× 296 1.0× 82 0.4× 71 2.1k
Yasushi Ito 1.1k 1.2× 320 0.5× 86 0.3× 110 0.4× 138 0.7× 43 2.1k
Davide Lecca 1.1k 1.1× 250 0.4× 111 0.4× 498 1.7× 147 0.8× 56 2.2k

Countries citing papers authored by Daniel R. Premkumar

Since Specialization
Citations

This map shows the geographic impact of Daniel R. Premkumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Premkumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Premkumar more than expected).

Fields of papers citing papers by Daniel R. Premkumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Premkumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Premkumar. The network helps show where Daniel R. Premkumar may publish in the future.

Co-authorship network of co-authors of Daniel R. Premkumar

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Premkumar. A scholar is included among the top collaborators of Daniel R. Premkumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Premkumar. Daniel R. Premkumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jane, Esther P., Matthew Halbert, Brian Golbourn, et al.. (2023). Targeting mitochondrial energetics reverses panobinostat‐ and marizomib‐induced resistance in pediatric and adult high‐grade gliomas. Molecular Oncology. 17(9). 1821–1843. 8 indexed citations
2.
Jane, Esther P., et al.. (2021). Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases. Molecular Oncology. 16(1). 219–249. 15 indexed citations
3.
Jane, Esther P., Daniel R. Premkumar, Brian Golbourn, et al.. (2020). Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance. Molecular Cancer Research. 18(7). 1004–1017. 13 indexed citations
4.
Jane, Esther P., et al.. (2016). Survivin inhibitor YM155 induces mitochondrial dysfunction, autophagy, DNA damage and apoptosis in Bcl‐xL silenced glioma cell lines. Molecular Carcinogenesis. 56(4). 1251–1265. 33 indexed citations
5.
Premkumar, Daniel R., et al.. (2016). Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737–Mediated Cell Death in Malignant Human Glioma Cell Lines. Journal of Pharmacology and Experimental Therapeutics. 356(2). 354–365. 36 indexed citations
6.
Jane, Esther P., Daniel R. Premkumar, Alejandro Morales, Kimberly A. Foster, & Ian F. Pollack. (2014). Inhibition of Phosphatidylinositol 3-Kinase/AKT Signaling by NVP-BKM120 Promotes ABT-737–Induced Toxicity in a Caspase-Dependent Manner through Mitochondrial Dysfunction and DNA Damage Response in Established and Primary Cultured Glioblastoma Cells. Journal of Pharmacology and Experimental Therapeutics. 350(1). 22–35. 31 indexed citations
7.
Jane, Esther P., Daniel R. Premkumar, Joseph D. DiDomenico, et al.. (2013). YM-155 Potentiates the Effect of ABT-737 in Malignant Human Glioma Cells via Survivin and Mcl-1 Downregulation in an EGFR-Dependent Context. Molecular Cancer Therapeutics. 12(3). 326–338. 30 indexed citations
8.
Premkumar, Daniel R., Esther P. Jane, Kimberly A. Foster, & Ian F. Pollack. (2013). Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor– Related Apoptosis-Inducing Ligand-Resistant Glioma Cells to Apoptosis through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway. Journal of Pharmacology and Experimental Therapeutics. 346(2). 201–210. 20 indexed citations
9.
Jane, Esther P., Daniel R. Premkumar, & Ian F. Pollack. (2011). Bortezomib Sensitizes Malignant Human Glioma Cells to TRAIL, Mediated by Inhibition of the NF-κB Signaling Pathway. Molecular Cancer Therapeutics. 10(1). 198–208. 63 indexed citations
10.
11.
Jane, Esther P., et al.. (2009). Abrogation of Mitogen-Activated Protein Kinase and Akt Signaling by Vandetanib Synergistically Potentiates Histone Deacetylase Inhibitor-Induced Apoptosis in Human Glioma Cells. Journal of Pharmacology and Experimental Therapeutics. 331(1). 327–337. 24 indexed citations
12.
Jane, Esther P., Daniel R. Premkumar, & Ian F. Pollack. (2007). AG490 influences UCN-01-induced cytotoxicity in Glioma cells in a p53-dependent fashion, correlating with effects on BAX cleavage and BAD phosphorylation. Cancer Letters. 257(1). 36–46. 15 indexed citations
13.
Jane, Esther P., Daniel R. Premkumar, & Ian F. Pollack. (2006). Coadministration of Sorafenib with Rottlerin Potently Inhibits Cell Proliferation and Migration in Human Malignant Glioma Cells. Journal of Pharmacology and Experimental Therapeutics. 319(3). 1070–1080. 82 indexed citations
14.
Wetzel, Matthew, Daniel R. Premkumar, Beth Arnold, & Ian F. Pollack. (2005). Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis. Journal of Neurosurgery Pediatrics. 103(6). 549–556. 46 indexed citations
15.
Adhikary, Gautam, et al.. (2002). Dual Influence of Nitric Oxide on Gene Regulation During Hyoixua. Advances in experimental medicine and biology. 475. 285–292. 9 indexed citations
16.
Cohen, David, Peter Hedera, Daniel R. Premkumar, Robert P. Friedland, & Raj N. Kalaria. (1997). Amyloid‐β Protein Angiopathies Masquerading as Alzheimer's Disease?a. Annals of the New York Academy of Sciences. 826(1). 390–395. 21 indexed citations
17.
Kalaria, Rajesh N., et al.. (1996). Cellular Aspects of the Inflammatory Response in Alzheimer's Disease. PubMed. 5(4). 497–503. 34 indexed citations
18.
Prabhakar, Nanduri R., et al.. (1996). Activation of nitric oxide synthase gene expression by hypoxia in central and peripheral neurons. Molecular Brain Research. 43(1-2). 341–346. 74 indexed citations
19.
Kalaria, R, et al.. (1996). Molecular aspects of inflammatory and immune responses in Alzheimer's disease. Neurobiology of Aging. 17(5). 687–693. 35 indexed citations
20.
Premkumar, Daniel R. & Raj N. Kalaria. (1996). Altered Expression of Amyloid β Precursor mRNAs in Cerebral Vessels, Meninges, and Choroid Plexus in Alzheimer's Diseasea. Annals of the New York Academy of Sciences. 777(1). 288–292. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christer Möller Breakdown of academic impact, for papers by Tomoko Kurata Breakdown of academic impact, for papers by Huang Guo Breakdown of academic impact, for papers by Virginia Hovanesian Breakdown of academic impact, for papers by Aimee W. Kao Breakdown of academic impact, for papers by Sybille Krauß Breakdown of academic impact, for papers by Nobuyuki Kimura Breakdown of academic impact, for papers by Ju Gao Breakdown of academic impact, for papers by Yasushi Ito Breakdown of academic impact, for papers by Davide Lecca
Rankless by CCL
2026